Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: no known allergies / adverse drug reactions attending: chief complaint: jaundice and abdominal pain major surgical or invasive procedure: ercp with stent placement history of present illness: 30 yo woman from with history of treated tuberculosis (per pt) who presented to osh with jaundice and abdominal pain, now transfered from osh for concert for cholangitis and sepsis in the setting of liver cyst. . the pt was originally admitted to osh on for abdominal pain and jaundice. ct scan during that admission showed intra and extrahepatic biliary duct dilatation with a large cystic component in the biliary duct and a suggestion of a choledochal cyst with associated infection/ inflammation. labs were notable for ast 103, alt 136, alk phos 450, hep b surface ag neg, hep b surface ab pos, hcv neg. the pt was treated with antibiotics and evaluated by the osh surgical team, and ultimately was discharged home on oral antibiotics, with plans to follow up with gi as an outpatient for ercp on . on the pt developed abdominal pain which was relieved with percocet. on the pt developed nausea and non-bloody emesis, and presented to osh ed. labs at that time were significant for wbc 13, hct 33, plt 279, with 16% eos. tbili was 3.8, ast 33, alt 59 and alk phos 457. chem 7 was normal. the pt's symptoms improved with supportive medications, but the pt was noted to have sbp's persistently low, sometimes in the 70's and was transfered to the osh icu. during the admission from , the pt was noted to have poor u/o, with only 2l out despite 11l in during her length of stay. the pt was initially started on ertapenem and flagyl for presumed cholangitis and pancreatitis, but then it was determined that ertapenem would provide adequate coverage and flagyl was stopped. the pt was kept npo, and did have an episode of hypoglycemia in the 40's that responded to an amp of d50. the pt was transfered to for ercp and hepatobiliary consults. . on the floor, sbp 96, otherwise the pt denies abdominal pain, nausea, lightheadedness. past medical history: tuberculosis, dx , per patient took 9 mos kanamycin, ethionamide. her strain was resistant to rifampin recent dx choledochal cyst . social history: no tobacco, alcohol or drugs. stays at home with 3 year old. married. is from indian, but tibetan. moved to usa one year ago. family history: non contributory physical exam: admission pe: general: alert, oriented, no acute distress heent: sclera anicteric, mmm, oropharynx clear neck: supple, jvp not elevated, no lad lungs: clear to auscultation bilaterally, no wheezes, rales, ronchi cv: regular rate and rhythm, normal s1 + s2, no murmurs, rubs, gallops abdomen: thin, soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly, liver edge palpable, no hsm gu: no foley ext: warm, well perfused, 2+ pulses, trace bilat le edema, pitting neuro: speech fluent, a+ox3, 5/5 strength in bilat upper and lower extremities. gait assessment deferred. discharge pe: afebrile 92/62 p75 18 100ra pertinent results: admission labs: 10:42pm blood wbc-8.3 rbc-3.94* hgb-10.2* hct-31.6* mcv-80* mch-25.9* mchc-32.3 rdw-15.5 plt ct-278 10:42pm blood neuts-41* bands-0 lymphs-18 monos-3 eos-38* baso-0 atyps-0 metas-0 myelos-0 10:42pm blood hypochr-2+ anisocy-1+ poiklo-1+ macrocy-normal microcy-1+ polychr-occasional ovalocy-1+ schisto-1+ 06:00am blood pt-14.8* ptt-40.3* inr(pt)-1.3* 10:42pm blood glucose-85 urean-3* creat-0.3* na-137 k-3.6 cl-111* hco3-17* angap-13 10:42pm blood alt-35 ast-31 ld(ldh)-157 alkphos-453* totbili-2.2* 10:42pm blood albumin-2.9* calcium-8.0* phos-1.7* mg-1.8 micro: stool o&p: negative echinococcus ab: positive entamoeba: pending fasciola: 1:8 negative strongyloides: negative schistosoma: negative mrcp: 1. diffuse irregular intra- and extrahepatic biliary dilation,with dominant massively dilated biliary structure encompassing the majority of the right hepatic lobe. this is felt most likely to represent diffuse choledochal cyst formation (todani type ). postinfectious biliary dilation is felt less likely due to lack of stricturing and lack of intraductal stones. appearance is not typical of echinococcal disease (as questioned). 2. diffuse peribiliary enhancement consistent with superinfection/cholangitis, and probable chronic right portal venous compression or occlusion with collateralization. however, short interval follow up after treatment and resolution of symptoms (within 3 months) is recommended to ensure resolution of enhancement about the cyst, in order to exclude an adjacent infiltrative mass. in addition, consideration of correlation with ercp and brushings is suggested. 3. perihepatic and subdiaphragmatic free fluid that could relate to inflammatory or infectious change or prior cyst rupture into the perihepatic space. 4. additional left sided intrahepatic biliary dilation and wall enhancement. differential includes cholangitis, biliary stasis, and obstruction by the dominant biliary cyst. ercp: extensive dilation of the common bile duct, common hepatic duct, intra and extrahepatic bile ducts. extensive stones and sludge throughout the extrahepatic and right intrahepatic biliary system. 1 cm biliary stricture noted in the right hepatic duct. proximal to this was severe dilation with debris inside consistent with patient's known biliary dilation/cyst. successful sphincterotomy performed. extraction of significant amount of stones/debris, although extensive debris remains in the right intrahepatic bile ducts at the end of the procedure. brushings taken of right hepatic duct stricture. successful stent placement across the hepatic duct stricture. findings most consistent with oriental cholangiohepatitis. ruq u/s: preliminary report !! pfi !! pfi: given limitations in comparing cross modalities, persisting cystic structure in the right kidney with heterogeneous echogenic material within it, similar in size to prior mr, and draining into a dilated bile duct. findings are nonspecific, and as advised on prior mr, ercp may be considered for further assessment. cxr: volume loss left upper lobe probably due to old lung infection, but mass effect is present. bile duct brushing cytology: negative for malignant cells. ct chest w/contrast study date of impression: 1. extensive findings consistent with prior tuberculose exposure. 2. no evidence of echinococcal infestation of lungs or mediastinum. 3. several noncalcified pulmonary nodules, most likely consistent with noncalcified granulomas. in the absence of smoking or known malignancy, as guidelines, no further followup indicated. discharge labs: 08:26 wbc 8.1 hgb 11.3 hct 33.5 plt 367 08:26 alt 30 ast 32 alk phos 441* tbili 1.2 07:05 lytes, bun/cr wnl brief hospital course: 30 year old tibetan woman with choledochal cyst of unknown etiology transferred from osh for ercp and hepatobiliary surgery consultation presented with hypotension, eosinophilia, elevated lfts and abdominal pain. # choledochal/hepatic cyst: ddx included echinococcus, amebic, or other parasitic cyst vs simple cyst vs. abscess vs. tumor. parasitic cyst was felt to be most likely due to eosinophilia and recent immigration from . serologies for echinococcus was positive at the outside hospital, multiple serologies at were sent which confirmed echinococcus positivity. note that entamoeba serology remains pending. albendazole was started empirically at the outside hospital prior to her transfer due to concern for echinoccal cyst and possible spillage leading to hypotension. the surgical service was consulted given communication of this cyst with the biliary tree and they recommended surgical removal of the cyst. plan was for pt to return to cha for surgical intervention, however, pt requested to have procedure done at . id was consulted and followed throughout the hospitalization. per id, pt will need to remain on albendazole for one month following surgical intervention. # cholangitis- ercp was consulted, as was hepatobiliary surgery and infectious disease.she underwent an ercp on and stones and sludge were removed. a sphincterotomy was performed and a stent was placed. her lfts improved after ercp, though there was no obvious change in the size of her cyst on imaging. she received empiric treatment with cipro, flagyl given concern for cholangitis/bacterial infection. she completed a two day course of ivermectin for possible strongyloides. her symptoms of nausea and abdominal pain improved. she will complete a 2 week course of cipro/flagyl per ercp recommendations, given the duration of her obstruction and the presence of the cyst. #hypotension: pt was hypotensive on admission, however this resolved with fluids and remained stable with careful monitoring throughout her stay in the icu. her baseline blood pressure is low, per pt. this may have been due to cholangitis/bacterial infection. however, given the possibility of an echinoccocal cyst, there was initial concern for anaphylaxis. however, she improved with ivf alone. medications on admission: on admission to osh) colace 100 percocet 5/325 q4h prn augmentin 875-125 x12d . (on transfer to ) flagyl 500mg iv q6- d/c'ed heparin 5000u tid ertapenem 1g q24h protonix 40iv daily albendazole 400mg (one dose at 6pm on ) discharge medications: 1. albendazole 200 mg tablet sig: two (2) tablet po bid (2 times a day): please continue for 1 month following surgery. disp:*120 tablet(s)* refills:*1* 2. ciprofloxacin 500 mg tablet sig: one (1) tablet po q12h (every 12 hours) for 8 days. disp:*16 tablet(s)* refills:*0* 3. metronidazole 500 mg tablet sig: one (1) tablet po q8h (every 8 hours) for 8 days. disp:*24 tablet(s)* refills:*0* discharge disposition: extended care discharge diagnosis: choledochal/hepatic cyst cholangitis hypotension eosinophilia discharge condition: mental status: clear and coherent. level of consciousness: alert and interactive. activity status: ambulatory - independent. discharge instructions: you were admitted with abdominal pain and were found to have blockage in your bile duct, this was opened up and stented with drainage of gallstones and sludge. you were also found to have a large fluid filled cyst pushing on your liver and liver veins; this cyst which communicates with/connects to the bile duct system. you will need to follow up with surgery to remove the cyst. followup instructions: surgery: please see dr. of surgery to discuss your surgical options. provider: , md phone: date/time: 3:00 pm. of the medical building at . a plan regarding your bile duct stent from ercp will be made at that time. with: , - location: cha- family health address: , phone: appointment: monday at 11:40am procedure: endoscopic removal of stone(s) from biliary tract endoscopic sphincterotomy and papillotomy endoscopic insertion of stent (tube) into bile duct diagnoses: anemia, unspecified unspecified septicemia severe sepsis septic shock hypovolemia cholangitis other specified hypoglycemia acute pancreatitis oliguria and anuria calculus of bile duct without mention of cholecystitis, with obstruction nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] personal history of tuberculosis abdominal pain, right upper quadrant eosinophilia echinococcosis, unspecified, of liver 

Answer: The patient is high likely exposed to